Zhejiang Haisen Pharmaceutical Co.,Ltd.(formerly the Dongyang Pharmaceutical Co.,Ltd.)is a medium-scale manufacturer enterprise engaged in the R&D, production and sales of APIS intermediates and food additives. With an occupied floor area of 150,000 sq.meters,a greening rate reaching 40% and an annual sales value exceeding 300 million RMB yuan, the company has more than 500 employees,36% of which are professional technicians. In 2005, the company set up the Dongyang Haisen Trading Co.,Ltd.which is mainly engaged in the import&export business. The company has obtained ISO9001,ISO14001 and GMP certificates, and the application for FDA and CEP certificates are just in the process.Sticking to the quality guideline of "Clients Paramount, All Employees Involved, Strict Criterion and Active Innovation", the company continuously expands the investment in high- and new- technology to achieve more economic benifits and more point of growth. The company has also established long-term friendly cooperative relationship with various scientific research institutes such as Sichuan Institute of Antibiotic Industry, Shanghai Institute of Pharmaceutical Industry, etc,which has kept our R&D level always in the leading position in China. Our main products include such APIS as paroxetine hydrochloride, granisetron hydrochloride, analgin, sucralfate, L-glutamine,citalopram HBr, intermediate such as N-methyl paroxetine ,HABA, etc., among which one is nation-level new product and three province-level high new-tech products. The company always enjoys a good social reputation. Since its establishment, it has been honored, for many consecutive years,as the honest-business enterprise by the provincial government and "AAA Credit Enterprise" by Bank of China. Being international market-oriented and sic-tech depended, we will, as usual, give full play to our own advantages and continuously provide the customers with more quality products and services, and we hope to cooperate with friends from all walks of life for mutual development.
